Cargando…
Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
Clinicians should be aware of new developments to familiarize themselves with pharmacokinetic and pharmacodynamic characteristics of new anticoagulant agents to appropriately and safely use them. For the moment, cardiologists and other clinicians also require to master currently available drugs, rea...
Autores principales: | Boroumand, Mohammadali, Goodarzynejad, Hamidreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466827/ https://www.ncbi.nlm.nih.gov/pubmed/23074569 |
Ejemplares similares
-
Cholesteryl ester transfer protein gene polymorphism (I405V) and premature coronary artery disease in an Iranian population
por: Goodarzynejad, Hamidreza, et al.
Publicado: (2016) -
The rs5888 single nucleotide polymorphism in scavenger receptor class B type 1 (SCARB1) gene and the risk of premature coronary artery disease: a case-control study
por: Goodarzynejad, Hamidreza, et al.
Publicado: (2016) -
Association between the Hepatic Lipase Promoter Region Polymorphism (-514 C/T) and the Presence and Severity of Premature Coronary Artery Disease
por: Goodarzynejad, Hamidreza, et al.
Publicado: (2017) -
Prothrombin Gene G20210A Variant in Angiographically Documented Patients with Coronary Artery Stenosis
por: Pourgholi, Leyla, et al.
Publicado: (2019) -
Analyzing Gensini Score as a Semi-Continuous Outcome
por: Kashani, Homa, et al.
Publicado: (2016)